Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory T-Cell Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06552572
What this trial is testing

Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Samsung Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Early research (Phase 1)Looking for participantsNCT06313957
What this trial is testing

LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed B-cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & Institute 42
Testing effectiveness (Phase 2)Looking for participantsNCT05648019
What this trial is testing

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Who this might be right for
Lymphoblastic LeukemiaLymphoblastic Leukemia in ChildrenLymphoblastic Leukemia, Acute Adult+3 more
KK Women's and Children's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03927105
What this trial is testing

Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
University of Michigan Rogel Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT05260957
What this trial is testing

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

Who this might be right for
Refractory Non-Hodgkin LymphomaRelapsed Non Hodgkin LymphomaAggressive Non-Hodgkin Lymphoma
Lazaros Lekakis 22
Not applicableUnknownNCT03624686
What this trial is testing

Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies

Who this might be right for
Leukemia
National Taiwan University Hospital 130
Testing effectiveness (Phase 2)Study completedNCT03575325
What this trial is testing

Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia

Who this might be right for
Lymphoid LeukemiaAcute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia+1 more
H. Lee Moffitt Cancer Center and Research Institute 11
Early research (Phase 1)Study completedNCT00182650
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Early research (Phase 1)Study completedNCT04088890
What this trial is testing

Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies

Who this might be right for
B-ALLB-cell Non Hodgkin LymphomaDLBCL+1 more
Matthew Frank 52
Very early researchEnded earlyNCT01878708
What this trial is testing

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
T-Cell LymphomaRelapsed T-Cell LymphomaRefractory T-Cell Lymphoma
Dana-Farber Cancer Institute 2
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Large-scale testing (Phase 3)UnknownNCT00020865
What this trial is testing

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03409432
What this trial is testing

Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
Lymphomatoid PapulosisPrimary Cutaneous Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more
John Reneau 26
Large-scale testing (Phase 3)Study completedNCT03349333
What this trial is testing

A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL

Who this might be right for
Refractory Peripheral T-Cell LymphomaRelapsed T-Cell Lymphoma
Mundipharma (China) Pharmaceutical Co. Ltd 85
Early research (Phase 1)Active Not RecruitingNCT05878184
What this trial is testing

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

Who this might be right for
Non Hodgkin LymphomaChronic Lymphocytic Leukemia
Sana Biotechnology 16
Not applicableUnknownNCT05206071
What this trial is testing

Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 100
Early research (Phase 1)Ended earlyNCT00671112
What this trial is testing

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
714leukemiaLymphoma
Brian Hill, MD, PhD 30
Testing effectiveness (Phase 2)Looking for participantsNCT03938987
What this trial is testing

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Relapsed Non Hodgkin LymphomaRelapsed Adult ALLRelapsed Pediatric ALL
University of Alberta 63
Testing effectiveness (Phase 2)UnknownNCT00008164
What this trial is testing

Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia

Who this might be right for
Childhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more
Herbert Irving Comprehensive Cancer Center 30
Next Page